Virios Therapeutics Inc. (VIRI) stock fell during current market. What’s behind this?

BIIB Stock

Virios Therapeutics Inc. (NASDAQ: VIRI) stock price plunged by 1.46% in the current market trading session. Virios Therapeutics is a medical biotechnology firm focusing on developing new, dual-mechanism antiviral medicines to address diseases like fibromyalgia that are initiated or sustained by viruses. >> 7 Top Picks for the Post-Pandemic Economy <<  VIRI stock Recent Update […]

Market Globalist
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.